NeoGenomics Inc. Common Stock vs Trane Technologies plc — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Trane Technologies plc trades at $471.85 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 49.1× NeoGenomics Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NEO | TT | |
|---|---|---|
Market Cap | $2.14B | $105.17B |
Volume | 2,228,400 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $19.91 | $503.46 |
52-Week Low | $7.19 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $2.44B | $108.47B |
Dividend Yield | — | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →